Faron Pharmaceuticals Oy (FARN.L) LSE

50.00

-1.5(-2.91%)

Updated at February 20 04:39PM

Currency In GBp

Valuation

Market Cap219.23M
Enterprise Value221.84M
P/E Ratio-2.89
PEG Ratio-0.43
Price/Sales Ratio0
Price/Book Ratio-0
Enterprise/Revenue0
Enterprise/EBITDA-5,464.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0
Return On Equity0

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-18,469
Net Income-25,920
Diluted EPS-0

Balance Sheet

Total Cash13.53M
Total Cash/Share125.99
Total Debt22.41M
Total Debt/Equity-1.38
Current Ratio1.89
Book Value Per Share-151.26

Price History

52-Week Change-70.59
52-Week High270
52-Week Low48.4
Moving Average 50 Days162.75
Moving Average 200 Days191.95

Statistics

Average Volume82,707
Shares Outstanding110.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor151:125
Last Split DateJune 04, 2024